Ceftazidime and Abdominal compartment syndrome - a phase IV clinical study of FDA data


Abdominal compartment syndrome is reported only by a few people who take Ceftazidime.

The phase IV clinical study analyzes which people take Ceftazidime and have Abdominal compartment syndrome. It is created by eHealthMe based on reports of 8,851 people who have side effects while taking Ceftazidime from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 27, 2022

8,851 people reported to have side effects when taking Ceftazidime.
Among them, 4 people (0.05%) have Abdominal compartment syndrome.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 8,871 Ceftazidime users for its effectiveness, alternative drugs and more.

What is Abdominal compartment syndrome?

Abdominal compartment syndrome (increased pressure in abdomen) is found to be associated with 506 drugs and 385 conditions by eHealthMe.

Number of Ceftazidime and Abdominal compartment syndrome reports submitted per year:

Could Ceftazidime cause Abdominal compartment syndrome?

Time on Ceftazidime when people have Abdominal compartment syndrome *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Abdominal compartment syndrome when taking Ceftazidime *:

  • female: 75 %
  • male: 25 %

Age of people who have Abdominal compartment syndrome when taking Ceftazidime *:

  • 0-1: 25 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 75 %
  • 60+: 0.0 %

Common drugs people take besides Ceftazidime *:

  1. Meropenem: 2 people, 50.00%
  2. Cytarabine: 2 people, 50.00%
  3. Cancidas: 2 people, 50.00%
  4. Ondansetron: 1 person, 25.00%
  5. Amlodipine: 1 person, 25.00%

Common side effects people have besides Abdominal compartment syndrome *:

  1. Relapsing Fever (bacterial infection characterized by recurring episodes of fever, headache, muscle and joint aches, and nausea): 2 people, 50.00%
  2. Fungal Infection: 2 people, 50.00%
  3. Death: 2 people, 50.00%
  4. Vascular Pseudoaneurysm (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity): 1 person, 25.00%
  5. Septic Shock (shock due to blood infection): 1 person, 25.00%
  6. Posterior Reversible Encephalopathy Syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss): 1 person, 25.00%
  7. Pathogen Resistance: 1 person, 25.00%
  8. Hepatic Necrosis (large portions of liver die off due to severe liver disease): 1 person, 25.00%
  9. Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 1 person, 25.00%

Common conditions people have *:

  1. Pneumonia: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftazidime and have Abdominal compartment syndrome?

Check whether Abdominal compartment syndrome is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Abdominal compartment syndrome and when was it recovered:

Expand to all the drugs that have ingredients of ceftazidime:

Alternative drugs to, pros and cons of Ceftazidime:

Common Ceftazidime side effects:

Browse all side effects of Ceftazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Abdominal compartment syndrome treatments and more:

COVID vaccines that are related to Abdominal compartment syndrome:

All the drugs that are associated with Abdominal compartment syndrome:

All the conditions that are associated with Abdominal compartment syndrome:

How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime (the active ingredients of Ceftazidime) and Ceftazidime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: